MGMA: Practices not ready for ICD-10; CMS must take action

Less than 10 percent of physician practices reported that they had made significant progress when rating their overall readiness for ICD-10 implementation, up only slightly (from 4.7 percent) since June 2013, when the Medical Group Management Association (MGMA) previously assessed readiness levels. The new research includes responses from more than 570 medical groups where more than 21,000 physicians practice.

“The critical coordination that must take place between practices and their software vendor, clearinghouse and health plan partners is simply not happening at the pace required for a seamless implementation. Very simply, ICD-10 is behind schedule,” said Susan L. Turney, MD, MS, MGMA president and CEO.

MGMA urges the Centers for Medicare & Medicaid Services (CMS) to immediately take action to help ensure that physician practices can successfully undertake such a massive transition, including:

  • Initiating complete end-to-end testing with physician practices, assessing claims throughout the entire business cycle;
  • Releasing all Medicare and Medicaid payment edits and advising commercial health plans to do the same;
  • Publishing on an ongoing basis the readiness level of all Medicare contractors and state Medicaid agencies;
  • Assessing the readiness and targeting outreach to practice management (PM) and EHR software vendors serving physician practices; and
  • Continuing to expand provider education efforts, especially to smaller and more vulnerable organizations.

“As the agency overseeing the nation’s largest health plan, it is imperative that CMS show leadership by reversing its position and begin end-to-end provider testing,” said Turney. “The publication of testing schedules, payment policies and readiness levels are all necessary actions for both CMS and practice trading partners in the private sector. Without this preparation, there will be significant increases in cash flow disruptions to practices that will affect the ability to treat patients.”

MGMA also revealed that more than 80 percent of respondents indicated that their PM software would require replacement or upgrading to accommodate ICD-10 diagnosis codes, up from 73.2 percent in June. Moreover, 81.8 percent indicate that their EHR needs to be replaced or upgraded, a jump from 65.3 percent in June. Less than half (41 percent) of respondents reported that their cost to upgrade or replace their PM system software will be covered by their vendor, with about 50 percent of respondents indicating that their vendor will cover the cost of their EHR replacement or upgrade. For those required to cover these software costs, they report an average cost of $11,500 per FTE physician for the PM upgrade or replacement and $12,885 for the EHR. This translates into a cost of $243,850 for a ten physician practice for the ICD-10 software alone.

Only 8.2 percent stated that they have begun or completed testing with their EHR vendor, compared to 4.7 percent in June. Slightly more than 10 percent of respondents reported that internal software testing had begun or is complete with their PM vendor, a slight increase from 5.9 percent in June.

In June, 70 percent of respondents stated they had not heard from their major health plans regarding the date on which ICD-10 testing would begin. Six months later, nearly 60 percent say they still have not heard from their health plans. Moreover, only 5.4 percent reported that they have begun testing with their major health plans. Almost 60 percent stated in June that they had not heard from their clearinghouse regarding a testing date, and nearly 50 percent indicate they still have not heard. Only 8.1 percent reported that they had started testing with their clearinghouse.

The number of respondents who indicated that they are concerned or very concerned about the expected changes to clinical documentation remained constant at about 89 percent. Similarly, about 89 percent reported in both January and June that they were concerned or very concerned about the loss of clinician productivity after implementation, and about 86 percent about the loss of coding staff productivity. Finally, the expected change in difficulty for clinicians to select appropriate diagnosis codes remains extremely high with nearly 98 percent expecting that it will be somewhat or much more difficult under ICD-10.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.